Finn P W, Kara C J, Douhan J, Van T T, Folsom V, Glimcher L H
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.
Proc Natl Acad Sci U S A. 1990 Feb;87(3):914-8. doi: 10.1073/pnas.87.3.914.
Interferon gamma (IFN-gamma) is a potent inducer of major histocompatibility complex (MHC) antigens during normal immune responses and in abnormal responses in autoimmune disease. In this report we identify two nuclear factors whose binding to the murine E beta class II MHC beta-chain gene is regulated by this cytokine. IFN-gamma stimulation of murine macrophages results in the appearance of increased binding of one protein complex, complex A, and decreased binding of a second, faster migrating protein complex, complex B. Although the contact residues for both of these proteins lie within the highly conserved Y-box transcriptional element, their binding specificity differs. The protein in complex B is a CCAAT-box-binding protein that may be similar or identical to NF-Y or YB1, previously identified class II Y-box-binding proteins. The DNA sequence requirements for the binding of the slower migrating complex, complex A, are not limited to CCAAT-box sequences but include sequences upstream of the Y box. These upstream sequences are required both for IFN-gamma-induced gene transcription and for IFN-gamma-induced modulation of binding activity. These data suggest a model in which upstream sequences contribute to formation of a lymphokine-regulated complex downstream. The IFN-gamma-induced binding protein described as complex A in this report differs from the IFN-gamma, -alpha, or -beta-induced nuclear factors previously identified.
干扰素γ(IFN-γ)在正常免疫反应以及自身免疫性疾病的异常反应过程中,是主要组织相容性复合体(MHC)抗原的强效诱导剂。在本报告中,我们鉴定出两种核因子,它们与小鼠EβⅡ类MHCβ链基因的结合受这种细胞因子调控。用IFN-γ刺激小鼠巨噬细胞,会导致一种蛋白复合物(复合物A)的结合增加,以及另一种迁移速度更快的蛋白复合物(复合物B)的结合减少。尽管这两种蛋白的接触残基都位于高度保守的Y盒转录元件内,但它们的结合特异性不同。复合物B中的蛋白是一种CCAAT盒结合蛋白,可能与先前鉴定的Ⅱ类Y盒结合蛋白NF-Y或YB1相似或相同。迁移速度较慢的复合物(复合物A)结合所需的DNA序列要求并不局限于CCAAT盒序列,还包括Y盒上游的序列。这些上游序列对于IFN-γ诱导的基因转录以及IFN-γ诱导的结合活性调节都是必需的。这些数据提示了一种模型,其中上游序列有助于下游形成受淋巴因子调节的复合物。本报告中描述为复合物A的IFN-γ诱导结合蛋白不同于先前鉴定的IFN-γ、α或β诱导的核因子。